myelodysplastic syndrome

Showing NaN - NaN of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • FT-2102 (olutasidenib)
  • +2 more
  • Los Angeles, California
  • +59 more
Mar 2, 2022

Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

Active, not recruiting
  • Anemia
  • +3 more
  • Epoetin Alfa
  • +2 more
  • Birmingham, Alabama
  • +512 more
Mar 1, 2022

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
Aug 16, 2021

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Gilbert, Arizona
  • +12 more
Jun 15, 2021

Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 12, 2021

Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Chicago (Fludarabine-Melphalan & Rabbit antithymocyte globulin

Completed
  • Leukemia
  • +3 more
  • Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
  • +4 more
  • Chicago, Illinois
    The University of Chicago
Jan 8, 2021

Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727

Completed
  • Myelodysplastic Syndrome
  • MDS
  • ASTX727 Dose Escalation
  • +2 more
  • Phoenix, Arizona
  • +16 more
Dec 1, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Multi-center, Survival Data Collection in Subjects Previously

Completed
  • Myelodysplastic Syndrome
    • Scottsdale, Arizona
    • +14 more
    Nov 6, 2019

    Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)

    Completed
    • Myelodysplastic Syndrome
    • MEDI4736 Evaluate MEDI4736 in MDS
    • +2 more
    • Scottsdale, Arizona
    • +20 more
    May 9, 2019

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, Hematologic Malignancies Trial in France, United States (AG881)

    Completed
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Aurora, Colorado
    • +5 more
    Mar 6, 2019

    Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))

    Terminated
    • Myelodysplastic Syndrome
    • vadastuximab talirine
    • +2 more
    • Gilbert, Arizona
    • +33 more
    Jan 23, 2019

    Myelodysplastic Syndrome Trial in Chicago (CC-1088)

    Completed
    • Myelodysplastic Syndrome
    • Chicago, Illinois
      Rush-Presbyterian-St Luke's Medical Center
    Apr 24, 2017

    Myelodysplastic Syndrome, MDS Trial in United States (pracinostat, Azacitidine, Decitabine)

    Completed
    • Myelodysplastic Syndrome
    • MDS
    • Mobile, Alabama
    • +20 more
    Feb 22, 2017

    Myelodysplastic Syndrome Trial in Chicago (Panhematin)

    Terminated
    • Myelodysplastic Syndrome
    • Chicago, Illinois
      Rush University Medical Center
    Oct 23, 2014

    Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Chicago (Ara-C, Mitoxantrone, Etoposide)

    Completed
    • Myelodysplastic Syndrome
    • Acute Myeloid Leukemia
    • Chicago, Illinois
      The University of Chicago
    Jan 16, 2014